Hyperventilation in neurological patients
| Autor: | Qulian Guo, E Wang, Zhong Zhang |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Treatment outcome
hyperventilation Carbon dioxide blood Brain Injuries Traumatic Hyperventilation medicine Humans Elevated Intracranial Pressure Evidence-Based Medicine Trauma Severity Indices business.industry traumatic brain injury Trauma Severity Indexes Oxygen metabolism Brain craniotomy Carbon Dioxide Subarachnoid Hemorrhage Respiration Artificial NEUROANESTHESIA: Edited by Lingzhong Meng Oxygen hypocapnia Treatment Outcome Anesthesiology and Pain Medicine Anesthesia Practice Guidelines as Topic outcome Intracranial Hypertension medicine.symptom business intracranial hemorrhage |
| Zdroj: | Current Opinion in Anaesthesiology |
| ISSN: | 0952-7907 |
| DOI: | 10.1097/aco.0000000000000764 |
| Popis: | Purpose of review Hyperventilation is commonly used in neurological patients to decrease elevated intracranial pressure (ICP) or relax a tense brain. However, the potentially deleterious effects of hyperventilation may limit its clinical application. The aim of this review is to summarize the physiological and outcome evidence related to hyperventilation in neurological patients. Recent findings Physiologically, hyperventilation may adversely decrease cerebral blood flow (CBF) and the match between the cerebral metabolic rate and CBF. In patients with severe traumatic brain injury (TBI), prolonged prophylactic hyperventilation with arterial carbon dioxide tension (PaCO2) less than 25 mmHg or during the first 24 h after injury is not recommended. Most patients (>90%) with an aneurysmal subarachnoid hemorrhage undergo hyperventilation (PaCO2 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|